Average Co-Inventor Count = 3.66
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rgenix, Inc. (6 from 6 patents)
2. Inspirna, Inc. (5 from 10 patents)
3. The Royal Institution for the Advancement of Learning / Mcgill University (3 from 295 patents)
4. Universitéde Montreal (3 from 183 patents)
5. Haro Pharmaceuticals Inc. (3 from 3 patents)
6. Euclises Pharmaceuticals, Inc. (3 from 3 patents)
7. California Institute of Technology (2 from 4,554 patents)
8. Holoclara, Inc. (2 from 2 patents)
9. Tansna Therapeutics, Inc. (1 from 1 patent)
10. Sea Pharmaceuticals LLC (1 from 1 patent)
11. Haro Pharmaceutical Inc. (0 patent)
21 patents:
1. 12473323 - Ascaroside derivatives and methods of use
2. 12258303 - Metal salts and uses thereof
3. 11878956 - Metal salts and uses thereof
4. 11845770 - Ascaroside derivatives and methods of use
5. 11685726 - Pharmaceutical compositions of 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and ester derivatives thereof
6. 11629118 - Formulations with improved stability
7. 11459292 - Metal salts and uses thereof
8. 11174220 - Metal salts and uses thereof
9. 10954194 - 18-20 member bi-polycyclic compounds
10. 10752591 - 18-20 member bi-polycyclic compounds
11. 10717704 - Inhibitors of creatine transport and uses thereof
12. 10669296 - LXR agonists and uses thereof
13. 10512623 - Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereof
14. 10377715 - 18-20 member bi-polycyclic compounds
15. 10308597 - Inhibitors of creatine transport and uses thereof